$TER

MATZ MARILYN sold $140K of TER

MATZ MARILYN sold 400 shares of TERADYNE, INC (TER) at $351.11 ($0.14M total) on 2026-09-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MATZ MARILYN
Published Sep 18, 2026, 3:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 3:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TER
Bearish
medium confidence
Mentioned
$TER
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider sentiment for Teradyne.

02

Market read

Small insider sale; limited immediate market impact but useful for monitoring insider activity.

03

What to watch

The director retains a sizable holding, indicating continued confidence.

Relevance 3/10Novelty 4/10Timing: filing date 2026-09-18

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$TERBearishMedium confidence
Context

Director Marilyn Matz sold 400 shares for $140,444 via a 10b5‑1 plan, reducing her stake to 13,841 shares.

Expected impact

Possible modest downward pressure in the near term.

Evidence & confidence

Sale size is modest relative to market cap, but director involvement adds weight.

Market effects

Minimal impact on semiconductor equipment sector.

None

Low

Counterpoint

Insider sale could be routine portfolio management, not a negative signal.

Key entities

  • Marilyn Matz

    Director of Teradyne who sold shares.

  • Teradyne, Inc.

    Manufacturer of automatic test equipment.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TERMed

Teradyne Partners With GS Microelectronics On New Semiconductor Test Center — Targets AI, Silicon Photonics And Auto Chips

Teradyne (TER) and GS Microelectronics U.S. (GSME) announced a multi-year partnership to establish a test-and-evaluation center for AI and next-generation chips. The facility, set to open in Q4 2026, will combine GSME's chip design and manufacturing with Teradyne's test systems. Teradyne's Semiconductor Test segment reported record Q2 revenue of $1.12 billion, up 128.1% YoY, driven by AI-related sales. Overall Q2 revenue was $1.33 billion, up 104% YoY. TER shares have risen nearly 90% YTD.

$FORMMedAI 8/10

FormFactor, Entegris, Penguin Solutions, Teradyne, and Marvell Technology Stocks Trade Up, What You Need To Know

Several semiconductor stocks rose after the August jobs report, which showed 162,000 nonfarm payroll jobs added, beating estimates. Despite initial expectations of a rate hike, traders rotated back into the chip sector. FormFactor (FORM) +5.3%, Entegris (ENTG) +5.6%, Penguin Solutions (PENG) +5.1%, Teradyne (TER) +4.8%, and Marvell Technology (MRVL) +6.2%. Marvell reported Q2 revenue of $2.74B, up 36.5% YoY, with strong Data Center demand. Management guided Q3 revenue at $3.15B, but revenue from

$TERMed

Teradyne Stock Plunges 15% in a Month: Should You Buy the Dip?

Teradyne (TER) shares fell 15.4% in a month, underperforming peers and sector. Challenges include customer concentration and muted demand, but AI-driven data center growth and strong Q3 guidance offset this. TER expects $1.20-$1.30B revenue and $1.85-$2.15 EPS for Q3 2026, up significantly YoY. The stock trades at a premium with a forward P/S of 9.35X.